In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 4

Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials

SARASOTA, Fla., May 16, 2013 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies have provided new evidence that its novel class of antimicrobials, named bisphosphocins, function through a completely unique mechanism of action involving bacterial membrane depolarization, resulting in rapid...

Quest Diagnostics Acquires Concentra's Laboratory Business, Enters into Exclusive Services Agreement

MADISON, N.J., May 16, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc. (NYSE: HUM).  In addition, Quest Diagnostics has entered into a long-term agreement with Concentra...

DNA Genotek Inc. Announces Spit for Africa Program

Program Includes Collaboration with the African Society of Human Genetics Ottawa, ON (PRWEB) May 16, 2013 DNA Genotek, a leading provider of products for biological sample collection, today announced ‘Spit for Africa’, a sponsorship program in conjunction with the African Society of Human Genetics (AfSHG). Spit for Africa is designed to improve access and reduce the cost of DNA collection for...

Source BioScience Interim Management Statement

16th May 2013: Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date. Unless otherwise stated, the financial information referenced below refers to the four months ended 30 April 2013, and the corresponding period last year, this being the latest practicable date to which f...

Personalized Medicine's Season

Wall Street Journal | The diagnostics market is its most attractive since 2007, and health care is the best performing sector of the public market right now.

AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies

SAN DIEGO, May 16, 2013 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract award from the U.S. government for the development of highly thermostable anti-ricin antibodies for biodefense applications.  Under the terms of AnaptysBio's contract with the Science and Technology Corporation, AnaptysBio will be responsible...

European Gynecological Device Market to reach more than $300 Million by 2021

TORONTO, May 16, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the gynecological device market in Europe will be fueled by the growing preference for minimally invasive gynecological procedures that can be performed in physician offices. Instead of a highly invasive hysterectomy, patients are opting...

Market Access Expert Firm, PRMA Consulting, Launches Companion Diagnostics Handbook

Companion diagnostics in oncology – Key questions manufacturers should ask to prepare for market access New York, NY (PRWEB) May 16, 2013 Leading UK company, PRMA Consulting launches PRMA Insights: Market Access Success for Companion Diagnostic–Drug Pairings in Oncology, a unique handbook that addresses the key issues that biopharmaceutical manufacturers should understand when developing new...

£40,000 awarded to innovative service development

Central Manchester University Hospitals NHS Foundation Trust (CMFT), alongside their partner MIMIT™, has awarded £40,000 as part of a new innovative award scheme.The CMFT Clinical Need Award was created, with a generous donation from the...

New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013

NORTHBROOK, IL -- (Marketwired) -- 05/16/13 -- Nanosphere, Inc. (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that new validation and outcome data for select Verigene® clinical microbiology tests will be presented at the 113th General Meeting of the American Society for Microbiology (ASM) being held in Denver, CO fro...

Brockville General Hospital Acquires Canada's First State-of-the-Art Sysmex XN-2000(TM) Automated Hematology Analyzer

BROCKVILLE, ON -- (Marketwired) -- 05/16/13 -- Ontario-based Brockville General Hospital and Sysmex Canada, Inc. today announced the hospital's installation and implementation of a Sysmex XN-2000™ Automated Hematology Analyzer. This is the first analyzer of the new Sysmex® XN-Series suite of products to be installed in Canada. This revolutionary compact automated hematology analyzer provides th...

Eutropics Pharmaceuticals to Present Data on Personalized Diagnostic for AML Patient Management at ASCO 2013

Study using Novel Biomarker Technology Indicates Potential Medical Utility in Discriminating Clinical Outcomes Eutropics Pharmaceuticals Inc. announced today that Eutropics and The University of Texas MD Anderson Cancer Center will present results from a clinical study employing Eutropics’ proprietary PraediCare Dx (BH3 profiling) assay to discrimina...

NanoString Technologies Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology (ASCO) Meeting on Sun...

Origins and implications of pluripotent stem cell variability and heterogeneity

Pluripotent stem cell lines differ in their capacity to differentiate into desired cell types in vitro. Genetic and epigenetic variations contribute to functional variability between cell lines and heterogeneity within single clones. Characterizing s...

Robert Edwards (1925–2013)

Pioneer of in vitro fertilization.

Reduced Oxygen Levels Could Double Neural Stem Cells’ Chance of Survival

Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according to a new study released today in STEM CELLS Translational Medicine. Durham, NC (PRWEB) May 15, 2013 Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological th...

Genomic Health's New Prostate Test May Extend The Stock's Upward Climb

By Amy Baldwin:Genomic Health, Inc.'s (GHDX) stock has risen over 31% in the last month. The molecular diagnostics company's upward swing may be due to an earlier announcement of an 8% increase in revenue, but what probably propelled the stock further in the last few days was that Genomic health announced its novel genetic test to gauge the aggressiveness of prostate cancer became available on the...

NICE to produce briefings on technologies

The U.K.'s NICE said it will publish about 40 "Medtech Innovation Briefings" annually to provide objective information on devices and diagnostics to help boost the uptake of the technologies within NHS. The agency said the briefings will describe the...

Quidel's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)

Quidel Corporation (QDEL) Bank of America Merrill Lynch Health Care Conference Call May 15, 2013 12:20 pm ET Executives Douglas C. Bryant – President and Chief Executive Officer Analysts Derik De Bruin – Bank of America Merrill Lynch Presentation Derik De Bruin – Bank of America Merrill Lynch [Starts Abruptly] To the 2013 Bank of America Merrill Lynch Health Care Confer...

Vermillion Reports First Quarter 2013 Results

AUSTIN, Texas, May 15, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and women's health, reported on its financial results for the first quarter ended March 31, 2013. Q1 2013 Financial ResultsTotal revenue in the first quarter of 2013 was $328,000, compared to $312,000 in the same year-ago quarter. First quarter 2013 revenue w...

SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel

New panels provide manufacturers with material from a variety of donor genotypes and recent collection periods. Milford, Massachusetts (PRWEB) May 15, 2013 SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, announced it has launched three new ACCUVERT™ seroconversion panels an...

Emerging Biomarker Companies Redux: Positioned For Growth

By Rod Raynovich: Biomarker Products for Cardiovascular Disease and Cancer This is the third article on Emerging Biomarker Companies. See 11/15/12 UpdateThe synergies between diagnostics and drugs are growing as more treatment options require better data for cost-effective, targeted therapeutics.The development of unique biomarkers has been considered the "Holy Grail" of innovation in diagnostic...

Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines

LA JOLLA, Calif. and ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- A team of international researchers from the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc. (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development Authority (BARDA, US Department of Health and Human Services), and Institut fur Virologie, Phillips Universitat, has published a study...

BioConference Live Hosts High Level Speakers from UCSF at Their Virtual Conference in May

The 4th Annual BioConference Live Clinical Diagnostics Virtual Conference presents cutting-edge research in clinical diagnostics May 29-31, 2013. Yorba Linda, CA (PRWEB) May 15, 2013 BioConference Live is a premiere producer of online conferences aimed at covering a variety of science verticals, including Clinical Diagnostics, Genetics & Genomics, Cancer Research & Discovery, and Laborato...

DxInsights Names Ethan K. Knowlden Executive Director

TUCSON, Ariz. and BOSTON, May 15, 2013 /PRNewswire/ -- DxInsights, a nonprofit, independent organization dedicated to educating industry, academicians, healthcare community and payers on the power of diagnostics, has announced the appointment of Ethan K. Knowlden as Executive Director.  Mr. Knowlden will work directly with DxInsights' Board and Steering Committee and will be responsible...